And with only half of that traded you can bet the underwriters are going to do everything they can to get the stock above 2.5. and much above for a profit. AGEN doubled after their offering in 1 month.
No coincidence that Roth capital presentation/conference is on Monday IMO
Investors do not need to worry about further dilution. Now we can focus on all the great news slated for this year and the news already disseminated.
Yes. AGEN priced their offering at 2.70 and 3 weeks later it is at 5 bucks. Nice thing about the offering is the volume and new set of investors and institutional ownership. The price was not bad but not great either.
DARA nice chart. lots of volume
How cool is that product. WAY COOL. handheld projector.... will be used by every businessman, student and anybody else who likes SUPER COOL.
Could it be? or something to do with warrants. Otherwise it seems like one big seller trying to get out and hopefully they are about done. They must be!
They have just received positive results for their bone marrow cancer drug. Very positive. Their pipeline is AMAZING. plenty of cash and only 68 million market cap. Multiple trial data due soon!
And the pipeline goes on and on. They have the best pipeline I have ever seen for a startup biotech!! Seriously.. only a 65 million market cap. Should be 650 million at least
so very undiscovered. Better pipeline than other biotechs with 10X the market cap. WAY BETTER PIPELINE. They have just announced the best treatment in history for bone marrow cancer and ????? 65 million market cap?? Should be trading at $34